Sign In
Buy AVEO
$15.00
+0 (+0%)
At Close: Apr 18, 2023
CORRECTION – AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Committee
03:22pm, Thursday, 28'th Mar 2024
– Industry veteran brings extensive clinical development experience to AVEO Oncology leadership team as Chief Medical Officer –
AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Committee
08:10am, Monday, 25'th Mar 2024
– Industry veteran brings extensive clinical development experience to AVEO Oncology leadership team as Chief Medical Officer –
BOSTON, Feb. 06, 2024 (GLOBE NEWSWIRE) -- AVEO Oncology , an LG Chem company (“AVEO”), today announced The Oncologist has published a post-hoc analysis of long-term progression free survival, over
BOSTON, Jan. 16, 2024 (GLOBE NEWSWIRE) -- AVEO Oncology (“AVEO”), an LG Chem company, today announced enrollment of the first patient in the FIERCE-HN trial, a global, multicenter, randomized, dou
4 Drug Stocks That More Than Doubled This Year
10:32am, Friday, 30'th Dec 2022
We present four biotech stocks, AVEO, CABA, VRNA and WVE, which despite the current volatile market, have provided more than twice the returns in 2022.
Are Medical Stocks Lagging AVEO Pharmaceuticals (AVEO) This Year?
11:17am, Monday, 26'th Dec 2022
Here is how AVEO Pharmaceuticals (AVEO) and Merit Medical (MMSI) have performed compared to their sector so far this year.
AVEO Oncology (AVEO): Strong Industry, Solid Earnings Estimate Revisions
12:02pm, Monday, 21'st Nov 2022
AVEO Oncology (AVEO) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
What Makes AVEO Pharmaceuticals (AVEO) a Strong Momentum Stock: Buy Now?
01:32pm, Monday, 14'th Nov 2022
Does AVEO Pharmaceuticals (AVEO) have what it takes to be a top stock pick for momentum investors? Let's find out.
AVEO Pharmaceuticals (AVEO) Reports Q3 Loss, Tops Revenue Estimates
08:19pm, Monday, 07'th Nov 2022
AVEO (AVEO) delivered earnings and revenue surprises of 43.75% and 1.67%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
AVEO Pharmaceuticals (AVEO) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
11:19am, Monday, 07'th Nov 2022
AVEO (AVEO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AVEO Oncology (AVEO) to Report Q3 Earnings: Is a Beat in Store?
12:47pm, Thursday, 27'th Oct 2022
AVEO Oncology's (AVEO) third-quarter earnings is expected to reflect strong Fotivda sales. The company is likely to beat the Zacks Consensus Estimate.
Are Medical Stocks Lagging AVEO Pharmaceuticals (AVEO) This Year?
11:18am, Friday, 21'st Oct 2022
Here is how AVEO Pharmaceuticals (AVEO) and Akero Therapeutics, Inc. (AKRO) have performed compared to their sector so far this year.
Why LG Chem Is Buying AVEO Oncology (AVEO) For $566 Million
07:32am, Wednesday, 19'th Oct 2022
LG Chem is buying AVEO Oncology for $566 million. These are the details.
Biopharma Stock Soaring on Buyout News
03:14pm, Tuesday, 18'th Oct 2022
Aveo Pharmaceuticals Inc (NASDAQ:AVEO) stock is soaring today, up 40.7% at $14.74 at last glance, after news that South Korean chemical company LG Chem plans to buy the biopharmaceutical name for $15
LG Chem to acquire AVEO Oncology for $566 million
01:12pm, Tuesday, 18'th Oct 2022
Yahoo Finance anchor Brad Smith breaks down how markets are trading, plus why AVEO stock is soaring today.
